background image

Boehringer Ingelheim Clinical Trials

Find clinical trials for Boehringer Ingelheim. Search for Boehringer Ingelheim clinical trials in different cities and states across the United States.

Filter
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Halifax, Moncton, Methuen MA, Riverhead NY, Hamden CT,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase3, Recruiting
New

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

for
Systemic Sclerosis
Location: South Miami FL, New Orleans LA, Austin TX, San Diego CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07497087

Phase3, Recruiting
New

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Knoxville TN, St Louis MO, Duarte CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07544654

Phase3, Recruiting
New

A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

for
Advanced Solid Cancer, Metastatic Solid Cancer
Location: New Haven CT, Nashville TN
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07607678

Phase1, Recruiting
New

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

for
Systemic Lupus Erythematosus
Location: Aventura FL, Duncansville PA, Tampa FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18 - 70+

Code: NCT07409181

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for
Solid Tumors
Location: New Haven CT, Hackensack NJ, Los Angeles CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05471856

Phase1, Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: New Haven CT, New York NY, Montreal, Wynnewood PA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase2, Recruiting

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

for
Kidney Disease, Chronic
Location: Halifax, Portsmouth NH, East Providence RI, Quebec,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06531824

Phase3, Recruiting

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

for
Small Cell Lung Carcinoma, Neuroendocrine Neoplasms,
Location: The Bronx NY, Baltimore MD, Richmond VA, Miami FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05882058

Phase2, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Boston MA, New Haven CT, New York NY, Fairfax VA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase1, Phase2, Recruiting